- Home
- NXDT vs SOPH Comparison
NXDT vs SOPH Comparison
Compare NXDT & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXDT
- SOPH
- Stock Information
- Founded
- NXDT 2012
- SOPH 2011
- Country
- NXDT United States
- SOPH Switzerland
- Employees
- NXDT N/A
- SOPH N/A
- Industry
- NXDT Investment Managers
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NXDT Finance
- SOPH Health Care
- Exchange
- NXDT Nasdaq
- SOPH Nasdaq
- Market Cap
- NXDT 227.2M
- SOPH 266.4M
- IPO Year
- NXDT N/A
- SOPH 2021
- Fundamental
- Price
- NXDT $4.95
- SOPH $4.09
- Analyst Decision
- NXDT
- SOPH Strong Buy
- Analyst Count
- NXDT 0
- SOPH 3
- Target Price
- NXDT N/A
- SOPH $7.00
- AVG Volume (30 Days)
- NXDT 133.6K
- SOPH 131.4K
- Earning Date
- NXDT 01-01-0001
- SOPH 03-04-2025
- Dividend Yield
- NXDT 9.66%
- SOPH N/A
- EPS Growth
- NXDT N/A
- SOPH N/A
- EPS
- NXDT 0.99
- SOPH N/A
- Revenue
- NXDT N/A
- SOPH $64,488,000.00
- Revenue This Year
- NXDT N/A
- SOPH $6.55
- Revenue Next Year
- NXDT N/A
- SOPH $14.37
- P/E Ratio
- NXDT $6.41
- SOPH N/A
- Revenue Growth
- NXDT N/A
- SOPH 9.85
- 52 Week Low
- NXDT $5.89
- SOPH $2.70
- 52 Week High
- NXDT $13.07
- SOPH $7.37
- Technical
- Relative Strength Index (RSI)
- NXDT 30.53
- SOPH 54.08
- Support Level
- NXDT $4.92
- SOPH $3.60
- Resistance Level
- NXDT $5.12
- SOPH $4.92
- Average True Range (ATR)
- NXDT 0.15
- SOPH 0.39
- MACD
- NXDT -0.02
- SOPH 0.04
- Stochastic Oscillator
- NXDT 3.80
- SOPH 49.54
About NXDT NexPoint Diversified Real Estate Trust
NexPoint Diversified Real Estate Trust is a publicly traded REIT focused on opportunistic real estate investments in the United States. Their portfolio includes diverse commercial properties and investments across various real estate sectors and capital structures. Revenue sources include rental income from office and retail properties, interest income from debt investments, dividend income from equity investments, and other ancillary income from tenants. The company operates primarily through its operating partnership and wholly owned subsidiaries.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.